Eric Van Cutsem
埃里克·范库特塞姆
MD, PhD
Professor of Internal Medicine; Head, Digestive Oncology Unit内科学教授；消化肿瘤学科主任
👥Biography 个人简介
Prof. Eric Van Cutsem at KU Leuven is among the most prolific and influential GI oncologists worldwide. He has led landmark trials across gastric and colorectal cancers, including seminal VEGF and EGFR inhibitor studies, and shaped global ESMO and ASCO treatment guidelines for decades.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Anti-VEGF and Anti-EGFR in GI Cancers
Conducted defining trials of bevacizumab, cetuximab, and ramucirumab in gastric and colorectal cancers, establishing anti-angiogenic and anti-EGFR therapy as treatment cornerstones globally.
Gastric Cancer First-Line Chemotherapy
Led the SPIRIT and ToGA trials contributing to trastuzumab plus chemotherapy becoming the global HER2-positive gastric cancer first-line standard, improving survival for this subtype.
Representative Works 代表性著作
Trastuzumab for gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
The Lancet (2010)
ToGA established trastuzumab plus chemotherapy as the first targeted first-line therapy for HER2-positive gastric cancer, a paradigm shift in the field.
Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer (CRYSTAL trial)
New England Journal of Medicine (2009)
Pivotal trial demonstrating cetuximab plus FOLFIRI improved PFS in KRAS wild-type mCRC, leading to the first biomarker-driven use of EGFR inhibitors in colorectal cancer.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Zev Wainberg
UCLA Health / David Geffen School of Medicine
Cathy Eng
Vanderbilt-Ingram Cancer Center
Daniel Coit
Memorial Sloan Kettering Cancer Center
Johanna Bendell
Sarah Cannon Research Institute
关注 埃里克·范库特塞姆 的研究动态
Follow Eric Van Cutsem's research updates
留下邮箱，当我们发布与 Eric Van Cutsem（University Hospitals Leuven / KU Leuven）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment